Tag Archives: Patent Law

Cert. Denied in Intema Ltd. v. PerkinElmer, Inc.

Posted on October 11, 2013 by Warren Woessner

On October 7, 2013, the S. Ct. denied cert., ending Intema’s appeal of the Fed. Cir. decision that its patent claims on a method to determine the level of risk of a Down syndrome pregnancy were not patent-eligible subject matter … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged biomarkers, biotechnology law, intellectual property, Intema, Mayo, Patent Law, Perkinelmer, USPTO, Warren Woessner | Leave a comment

Skinmedica, Inc. and, i.e., Disclaimer

Posted on October 2, 2013 by Warren Woessner

The Fed. Cir. has been pretty hard on defendants alleging disclaimer of claim scope in recent decisions but that was not the case here. But what caught my attention is that Judge Prost spent four pages of his opinion on … Continue reading →

Posted in Claim Interpretation | Tagged biotechnology, biotechnology law, Federal Circuit, intellectual property, ip, Judge Prost, Patent Law, patents, Skinmedica v Histogen, Warren Woessner | 3 Comments

Intema Files Petition for Grant of Certification

Posted on September 26, 2013 by Warren Woessner

Following the Fed. Cir. holding that the claims in Intema’s patent (U.S. Pat. No. 6,573,103) on an improved method for determining the risk of a Down’s syndrome pregnancy were patent-ineligible as directed to a law of nature and a mental … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged Down's Syndrom Pregnancy, Federal Circuit, intellectual property, Intema, Mayo, Myriad, Patent Law, Warren Woessner | Leave a comment

Dr. Watson, Genomics and the Law

Posted on September 3, 2013 by Warren Woessner

Since the legal tsunami of court decisions affecting many aspects of life sciences – from patents on Round-UpTM Ready soybeans to “companion diagnostics” – has rolled back out to the sea of summer break, I have found time to reflect … Continue reading →